News round-up by DDW’s Reece Armstrong for 18-22 April
Covid-19, the link between ageing and genetic mutations, alongside funding opportunities for drug developers are some of the themes of this week’s news round-up.
Animals with a large difference in lifespan and size end their natural lives with a similar number of genetic changes, researchers have discovered. The findings come from a study by the Wellcome Sanger Institute which analysed genomes from 16 species of mammal to understand the role genetic changes play in ageing and the development of cancer.
Biotech company ReiThera is collaborating with contract development and manufacturing organisation (CDMO) Exothera on a project to develop Covid-19 and HIV vaccines for low-and middle-income countries (LMIC).
BioXcel Therapeutics has raised $260 million in funding to support the commercial activities of its proprietary, orally dissolving film formulation IGALMI.
An increasing number of approvals and Emergency Use Authorisations (EUAs) by the Food and Drug Administration (FDA) for Covid-19 vaccines and drugs, as well as cell and gene therapies, is helping provide manufacturing opportunities for contract manufacturing organisations (CMOs).
Clinical trial support organisation Medical Research Network (MRN) has won a Queen’s Award for Enterprise for International Trade for its work in helping enhance the delivery of clinical trials through decentralisation technology.